Primary Objective
* To evaluate the efficacy of aripiprazole long acting injectable form in Turkish patients with schizophrenia on psychosocial functioning, quality of life and patient reported acceptability of treatment. Secondary Objective(s)
* To evaluate the cognitive functioning of the patients
* To evaluate positive and negative symptoms of the Aripiprazole Long Acting Injectable (LAI),
* To evaluate adherence of Aripiprazole Long Acting Injectable (LAI) treatment,
* To evaluate tolerability of Aripiprazole Long Acting Injectable (LAI).